Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Microrobot Swarm Breaks Up Bacterial Biofilms #Science #Business
    about 46 mins ago
  • After Pentagon Ends Contract, Top-Secret Scientists Group Vows To Carry On ... "We're very…
    about 14 hours ago
  • Hospital, academic, and industry researchers devised automated techniques including artificial intelligence to shar…
    about 18 hours ago
  • New post on Science and Enterprise: A.I. Speeds Infant Genetic Disease Diagnostics #Science #Business
    about 18 hours ago
  • A neuroscience lab created a virtual speech-generating vocal system that produces natural sounding human speech by…
    about 24 hours ago

Please share Science & Enterprise

Follow by Email
Visit Us

U.S. Patent Issued for Stem Cell Wound Care Technology

Stem Cells (NSF)

Stem Cells (National Science Foundation)

Stemedica Cell Technologies Inc. in San Diego has been granted a patent for its scaffolding technology based on adult stem cells used in healing wounds. Patent number 8,105,380 was awarded to Ludmilla and Alex Kharazi, Stemedica’s senior scientist and chief technology officer respectively, by the United States Patent and Trademark Office on 31 January 2012.

The patent covers Stemedica’s process for building a scaffold seeded with mesenchymal stem cells — those that transform into multiple cell types — and ectodermal or outer skin cells in a sandwich-like array. The scaffold provides a form for regenerating tissue, particularly for healing severely damaged tissue found in burns and wounds.

The company’s technology includes a biodegradable layer that enhances tissue growth and delivery of cytokines — proteins that encourage cell signaling and respond to infections — and a non-absorbable biological bandage layer that encourages closure of the broken skin. The scaffold is designed to mimic human skin and suitable for transplantation.

Stemedica is a licensed manufacturer of adult stem cells for pre-clinical research and clinical trials. The company is involved in a phase 1-2 clinical study of bone marrow stem cells to treat ischemic stroke, where blood to the brain is blocked. Stemedica is also conducting pre-clinical research in the use of neural stem cells to treat spinal cord injuries.

Read more:

*     *     *

Please share Science & Enterprise ...

2 comments to U.S. Patent Issued for Stem Cell Wound Care Technology